Meong Hi Son

857 citations
49 papers · 583 indexed · h-index 14
Topics
Neuroblastoma Research and Treatments (12 papers)Hematopoietic Stem Cell Transplantation (9 papers)Cancer therapeutics and mechanisms (7 papers)
Journals
SHILAP Revista de lepidopterologíaBloodPLoS ONE
Partner nations
South KoreaCanadaGermany

In The Last Decade

Meong Hi Son

46 papers receiving 577 citations

Peers

Meong Hi Son
Comparison fields: 5 of 90
  • Molecular Biology 220
  • Genetics 186
  • Neurology 159
  • Surgery 112
  • Cancer Research 112
Replace Robin Buerki with:
Robin Buerki United States
Junichi Iida Japan
Hirokazu Takami Japan
Tyler D. Menge United States
Matteo Lucchini Italy
Stephan Dützmann Germany
Xiao–Tang Kong United States
Hirotomo Tanaka Japan
Lillian Tseng United States
Nicoletta Orlando Italy
Meong Hi Son relative to Robin Buerki United States Robin Buerki's profile →
Citations per field
00.5×5.4×
Robin Buerki · 1×
Citations per year

Countries citing papers authored by Meong Hi Son

Since Specialization
Citations

This map shows the geographic impact of Meong Hi Son's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meong Hi Son with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meong Hi Son more than expected).

Fields of papers citing papers by Meong Hi Son

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meong Hi Son. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meong Hi Son. The network helps show where Meong Hi Son may publish in the future.

Co-authorship network of co-authors of Meong Hi Son

This figure shows the co-authorship network connecting the top 25 collaborators of Meong Hi Son. A scholar is included among the top collaborators of Meong Hi Son based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meong Hi Son. Meong Hi Son is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 7
4 6
5 1
6 0
7 13
8 1
9 3
10 1
11 5
12 5
13 43
14 59
15 30
16 41
17 4
18 42
19 1
20 18

About Meong Hi Son

Meong Hi Son is a scholar working on Hematology, Genetics and Neurology, having authored 49 papers that have together received 583 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (12 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Genetics (186 citations), Neurology (159 citations) and Hematology (102 citations). Meong Hi Son has collaborated with scholars based in South Korea, Canada and Germany. Frequent co-authors include Ki Woong Sung, Keon Hee Yoo, Hong Hoe Koo, Soo Hyun Lee, Hye Lim Jung, Ji Won Lee, Hee Won Cho, Myoung Woo Lee, In Keun Jang and Dae Seong Kim. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026